R
Research Grid (R.grid)
AI-powered automation engine for admin-free clinical trials
About Research Grid (R.grid)
Research Grid (R.grid) is a technology company that has developed an AI-native automation engine to streamline clinical trials. Founded in 2020 by Dr. Amber Hill, a former medical researcher with a PhD in biomedical neuroscience and a background in AI research technology, the company aims to make clinical trials faster and more successful by automating administrative tasks. Dr. Hill identified the problem of researchers being burdened with excessive back-office paperwork and set out to create a solution that eliminates manual administration from patient sourcing to trial management.
Read full description
The company is headquartered in London, United Kingdom, and has raised a total of $7.98 million over four funding rounds. A significant seed round of $6.5 million was raised in November 2024, led by Fuel Ventures with participation from multiple other venture capital firms and angel investors. This funding is intended to support research and development, expand engineering teams, and grow marketing and sales functions for expansion into US and Asian markets.
R.grid offers two main products: Inclusive and TrialEngine. Inclusive is a patient and community engagement platform used for the early trial preparation phase, facilitating participant sourcing, communication, and management. TrialEngine is a smart clinical trial automation system (CTAS) that manages administration, data, and reporting workflows throughout the trial and post-trial phases. Together, these platforms provide an end-to-end solution for managing the entire clinical trial lifecycle. The software is designed to be secure and compliant with regulations such as HIPAA and GDPR.
R.grid's platform leverages custom AI algorithms and process automation to perform tasks like protocol development, document creation, and data extraction in minutes, tasks that could take months with legacy systems. Features include a no-code CRF (Case Report Form) designer, real-time data oversight, document management with smart templates, and tools for site feasibility analysis and financial planning. By automating these processes, the company helps its customers achieve significant efficiency gains, cost savings, and increased patient engagement. The business model is Software as a Service (SaaS), serving clients in the biotechnology, pharmaceutical, and healthcare software industries.
At a glance
- Founded
- 2018
- Headquarters
- Norwich, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed10 investors entered at this stage
Ada Ventures
Ascension Ventures
Impact X Capital
Google for Startups Accelerator
Fuel Ventures
Arve Capital
Araya
Morgan Stanley Inclusive Ventures Lab
Atomico
Plug and Play
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Research Grid (R.grid) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Research Grid (R.grid) on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.